SCHEMBL3144040

SCHEMBL3144040

CCOC(OCC)N(CC)CC

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.42
LMNA P02545 1/20 0.40
FDPS P14324 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3150302 0.86 THRB (0.36) THRBLMNAFDPS
SCHEMBL9586671 0.77 FDPS (0.33) FDPS
SCHEMBL3137850 0.77 FDPS (0.41) THRBLMNAFDPS
SCHEMBL9586122 0.75 FDPS (0.32) FDPS
SCHEMBL6666446 0.73 LMNA (0.45) THRBLMNAFDPS
SCHEMBL11540531 0.73 THRB (0.40) THRBLMNA
SCHEMBL27780138 0.73 THRB (0.40) THRBLMNAFDPS
SCHEMBL10992824 0.73 THRB (0.35) THRBLMNA
SCHEMBL9586905 0.73 ADRB2 (0.36) FDPS
SCHEMBL448145 0.71 FDPS (0.32) FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4206205-B1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND PRIMEGENE BEIJING CO LTD (CN) 2026-03-04 EP claimed
US-20230303578-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND PRIMEGENE (BEIJING) CO., LTD. (CN) 2023-09-28 US claimed
EP-4206205-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND Primegene (Beijing) Co., Ltd. (CN) 2023-07-05 EP claimed
WO-2022042577-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND 北京普祺医药科技有限公司 2022-03-03 WO claimed
CN-103030598-B The preparation method of methoxy acrylic bactericide SHANGHAI HEBEN PHARMACEUTICAL CO., LTD. (CN) 2016-04-13 CN claimed
CN-103626691-B The preparation method of ZEN 90160 Shanghai Heben-Eastsun Medicaments Co., Ltd. (CN) 2015-10-21 CN claimed
CN-104151233-A Preparation method of agricultural bactericide ZHEJIANG TIDE CROP TECHNOLOGY CO LTD 2014-11-19 CN claimed
CN-103626691-A Picoxystrobin preparation method SHANGHAI HEBEN EASTSUN MEDICAMENTS CO LTD 2014-03-12 CN claimed
CN-103030598-A Method for preparing strobilurin fungicide SHANGHAI HEBEN EASTSUN MEDICAMENTS CO LTD 2013-04-10 CN claimed
US-3952007-A Processes for preparing 5-nitro-1-methyl-2-(2-dialkylaminovinyl)-imidazole and 5-nitro-1-methyl-2-imidazolyl carboxaldehyde SCHERING AKTIENGESELLSCHAFT (DT) 1976-04-20 US claimed
EP-4206205-B1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND PRIMEGENE BEIJING CO LTD (CN) 2026-03-04 EP disclosed
CN-120059762-A Liquid crystal aligning agent for forming weak anchor film, method for producing liquid crystal aligning film, and method for producing liquid crystal element JSR株式会社 2025-05-30 CN disclosed
WO-2025047698-A1 PHOTOSENSITIVE COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING SAME, LIQUID CRYSTAL DEVICE, SEMICONDUCTOR DEVICE, POLYMER, AND COMPOUND JSR株式会社 2025-03-06 WO disclosed
CN-118667558-A Liquid crystal aligning agent, liquid crystal alignment film and method for producing the same, liquid crystal element and method for producing the same JSR株式会社 2024-09-20 CN disclosed
CN-118530734-A Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal element, polymer, and compound JSR株式会社 2024-08-23 CN disclosed
US-4415580-A Certain 2-(1H)-pyridinones cardiotonic compositions containing same and method of using same STERLING DRUG INC. (US) 1983-11-15 US disclosed
EP-0089730-A2 Guanidino heterocyclicphenylamidines, processes for their preparation and their pharmaceutical use ISTITUTO DE ANGELI S.p.A. (IT) 1983-09-28 EP disclosed
US-4175087-A ENAMINOKETONES WITH ALKYLLITHIUM ELI LILLY AND COMPANY (US) 1979-11-20 US disclosed
US-3956492-A SEDATIVES, MUSCLE RELAXANTS, TRANQUILIZERS, ANTICONVULSANTS BOEHRINGER INGELHEIM GMBH (DT) 1976-05-11 US disclosed
US-3952007-A Processes for preparing 5-nitro-1-methyl-2-(2-dialkylaminovinyl)-imidazole and 5-nitro-1-methyl-2-imidazolyl carboxaldehyde SCHERING AKTIENGESELLSCHAFT (DT) 1976-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303578-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND DPYD, RPLP2, DHPS THRB 4571/4885LMNA 4225/4885FDPS 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.